Banque Cantonale Vaudoise Acquires 10,626 Shares of Colgate-Palmolive Company $CL

Banque Cantonale Vaudoise boosted its holdings in Colgate-Palmolive Company (NYSE:CL) by 29.5% in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 46,678 shares of the company’s stock after purchasing an additional 10,626 shares during the period. Banque Cantonale Vaudoise’s holdings in Colgate-Palmolive were worth $3,731,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. Vestcor Inc increased its stake in Colgate-Palmolive by 2.6% in the 3rd quarter. Vestcor Inc now owns 296,010 shares of the company’s stock worth $23,663,000 after purchasing an additional 7,542 shares during the period. Fieldview Capital Management LLC bought a new stake in Colgate-Palmolive during the 3rd quarter valued at $4,760,000. Inceptionr LLC bought a new stake in Colgate-Palmolive during the 3rd quarter valued at $628,000. Private Advisor Group LLC boosted its position in Colgate-Palmolive by 2.4% during the 3rd quarter. Private Advisor Group LLC now owns 79,095 shares of the company’s stock valued at $6,323,000 after buying an additional 1,826 shares during the period. Finally, Diversify Advisory Services LLC grew its holdings in Colgate-Palmolive by 33.3% in the 3rd quarter. Diversify Advisory Services LLC now owns 17,470 shares of the company’s stock worth $1,310,000 after acquiring an additional 4,367 shares during the last quarter. 80.41% of the stock is currently owned by hedge funds and other institutional investors.

Colgate-Palmolive Price Performance

CL stock opened at $92.45 on Wednesday. The company has a debt-to-equity ratio of 18.82, a current ratio of 0.83 and a quick ratio of 0.54. Colgate-Palmolive Company has a 1 year low of $74.54 and a 1 year high of $99.33. The firm has a 50-day moving average of $89.50 and a 200 day moving average of $83.13. The company has a market cap of $74.52 billion, a P/E ratio of 35.29, a PEG ratio of 4.17 and a beta of 0.28.

Colgate-Palmolive (NYSE:CL) last posted its earnings results on Friday, January 30th. The company reported $0.95 earnings per share for the quarter, topping analysts’ consensus estimates of $0.91 by $0.04. Colgate-Palmolive had a return on equity of 353.72% and a net margin of 10.45%.The firm had revenue of $5.23 billion for the quarter, compared to the consensus estimate of $5.13 billion. During the same quarter in the prior year, the business earned $0.91 EPS. The business’s revenue for the quarter was up 5.8% on a year-over-year basis. On average, sell-side analysts forecast that Colgate-Palmolive Company will post 3.75 EPS for the current year.

Analysts Set New Price Targets

CL has been the topic of a number of analyst reports. Evercore boosted their price objective on shares of Colgate-Palmolive from $94.00 to $100.00 and gave the company an “outperform” rating in a research report on Monday, February 2nd. The Goldman Sachs Group reiterated a “buy” rating and set a $100.00 target price on shares of Colgate-Palmolive in a report on Friday, February 20th. Jefferies Financial Group boosted their price target on Colgate-Palmolive from $85.00 to $91.00 and gave the company a “hold” rating in a report on Monday, February 2nd. Morgan Stanley upped their price target on Colgate-Palmolive from $87.00 to $100.00 and gave the company an “overweight” rating in a research report on Monday, February 2nd. Finally, Wells Fargo & Company increased their price objective on Colgate-Palmolive from $86.00 to $94.00 and gave the stock an “equal weight” rating in a report on Sunday, February 1st. Eleven analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $94.75.

Insider Buying and Selling at Colgate-Palmolive

In related news, COO Panagiotis Tsourapas sold 15,000 shares of the business’s stock in a transaction dated Thursday, February 12th. The shares were sold at an average price of $97.81, for a total transaction of $1,467,150.00. Following the sale, the chief operating officer owned 10,415 shares of the company’s stock, valued at $1,018,691.15. The trade was a 59.02% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, CFO Stanley J. Sutula III sold 97,843 shares of the company’s stock in a transaction dated Wednesday, February 4th. The stock was sold at an average price of $94.27, for a total transaction of $9,223,659.61. Following the completion of the sale, the chief financial officer owned 55,310 shares in the company, valued at approximately $5,214,073.70. This trade represents a 63.89% decrease in their position. The SEC filing for this sale provides additional information. In the last quarter, insiders have sold 184,683 shares of company stock worth $17,486,693. Corporate insiders own 0.41% of the company’s stock.

About Colgate-Palmolive

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.